1.02144
磷酸氢钙
anhydrous, fine powder, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 341(ii)
别名:
Calcium hydrogen phosphate, Calcium orthophosphate, Calcium phosphate dibasic
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
HCaO4P
化学文摘社编号:
分子量:
136.06
UNSPSC Code:
12352302
E Number:
E341 (ii)
EC Index Number:
231-826-1
MDL number:
产品名称
磷酸氢钙, anhydrous, fine powder, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 341(ii)
SMILES string
[Ca+2].[P](=O)([O-])([O-])[O-].[H+]
InChI
1S/Ca.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+2;/p-2
InChI key
FUFJGUQYACFECW-UHFFFAOYSA-L
agency
BP
Ph. Eur.
USP
reg. compliance
FCC
product line
EMPROVE® ESSENTIAL
form
fine powder
potency
10000 mg/kg LD50, oral (Rat)
>7940 mg/kg LD50, skin (Rabbit)
particle size
(see specification)
pH
7 (20 °C, 10 g/L in H2O, suspension)
mp
370 °C (decomposition)
density
2.89 g/cm3 at 20 °C
application(s)
pharmaceutical
semi-solid formulation
solid formulation
storage temp.
2-30°C
Quality Level
Application
Calcium hydrogen phosphate is a commonly used ingredient in both food and pharmaceutics. In pharmaceutical applications, calcium hydrogen phosphate is primarily used as a filler/binder.
General description
To address challenges of solid formulation manufacturing, we have developed a comprehensive product portfolio to meet with your solid dosage needs in mind. Although solid dose formulations are one of the the most established dosage forms in the pharmaceutical market, the complexity of manufacturing final drug products is becoming more and more challenging. API stability, release kinetics and bioavailability limitations, such as low API solubility, are just a few of many critical obstacles on the way to the market.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
13 - Non Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持